ActivX Biosciences Inc. is a biopharmaceutical company that discovers and develops highly selective, best in class, small molecule drugs for major unmet medical needs. ActivX uses its unique technology to identify target and off-target activities of drug candidates in the protein kinase and protease families with a focus on the areas of oncology, hematology, metabolic and inflammatory diseases. Our core technology allows identification and development of highly selective drugs, lowering development risks.